Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Gomez

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Lipids in Health and Disease|September 2, 2025
From guidelines to practice: LDL-C achievement in very high cardiovascular risk patients - analysis of the EDHIPO MARCA registryBrayan Daniel Cordoba-Melo, Sebastián Seni-Molina, Juan Pablo Arango-Ibanez, et al.
Frontiers in Cardiovascular Medicine|March 4, 2025
Impact of myocardial injury on cardiovascular complications in hospitalized patients with COVID-19: insights from Latin AmericaPaula Andrea Cárdenas-Marín, Brayan Daniel Cordoba-Melo, Diana Cristina Carrillo-Gómez, et al.
Global Heart|December 8, 2025
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: ResultsFernando Wyss, Ricardo Lopez-Santi, Daniel Piskorz, et al.
Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.
Journal of Cardiac Failure|March 5, 2021
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureBiykem Bozkurt, Andrew Js Coats, Hiroyuki Tsutsui, et al.
American Heart Journal|June 19, 2026
Registry of Atrial Fibrillation in Latin America: Primary Results of the LACROSS StudyPedro Gabriel Melo de Barros E Silva, Lucas Damiani, Paola Engelmann Arantes, et al.
European Journal of Heart Failure|February 19, 2021
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure AssociationBiykem Bozkurt, Andrew J S Coats, Hiroyuki Tsutsui, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
Kidney International Reports|July 25, 2022
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis PatientsRubén Torres, Luis Toro, María Eugenia Sanhueza, et al.
The New England Journal of Medicine|February 22, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Frank W G Leebeek, Michael Recht, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Lipids in Health and Disease|September 2, 2025
From guidelines to practice: LDL-C achievement in very high cardiovascular risk patients - analysis of the EDHIPO MARCA registryBrayan Daniel Cordoba-Melo, Sebastián Seni-Molina, Juan Pablo Arango-Ibanez, et al.
Frontiers in Cardiovascular Medicine|March 4, 2025
Impact of myocardial injury on cardiovascular complications in hospitalized patients with COVID-19: insights from Latin AmericaPaula Andrea Cárdenas-Marín, Brayan Daniel Cordoba-Melo, Diana Cristina Carrillo-Gómez, et al.
Global Heart|December 8, 2025
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: ResultsFernando Wyss, Ricardo Lopez-Santi, Daniel Piskorz, et al.
Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.
Journal of Cardiac Failure|March 5, 2021
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureBiykem Bozkurt, Andrew Js Coats, Hiroyuki Tsutsui, et al.
American Heart Journal|June 19, 2026
Registry of Atrial Fibrillation in Latin America: Primary Results of the LACROSS StudyPedro Gabriel Melo de Barros E Silva, Lucas Damiani, Paola Engelmann Arantes, et al.
European Journal of Heart Failure|February 19, 2021
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure AssociationBiykem Bozkurt, Andrew J S Coats, Hiroyuki Tsutsui, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
Kidney International Reports|July 25, 2022
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis PatientsRubén Torres, Luis Toro, María Eugenia Sanhueza, et al.
The New England Journal of Medicine|February 22, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Frank W G Leebeek, Michael Recht, et al.
Pageof 6